Natural Killer Cells: Development, Maturation, and Clinical Utilization.
Natural Killer Cells: Development, Maturation, and Clinical Utilization.
复制标题
DOI:
10.3389/fimmu.2018.01869
复制
发表时间:
2018
影响因子:
7.3
通讯作者:
Malarkannan S
中科院分区:
文献类型:
--
作者:
Abel AM;Yang C;Thakar MS;Malarkannan S
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells do not express polymorphic clonotypic receptors and utilize inhibitory receptors (killer immunoglobulin-like receptor and Ly49) to develop, mature, and recognize “self” from “non-self.” The essential roles of common gamma cytokines such as interleukin (IL)-2, IL-7, and IL-15 in the commitment and development of NK cells are well established. However, the critical functions of pro-inflammatory cytokines IL-12, IL-18, IL-27, and IL-35 in the transcriptional-priming of NK cells are only starting to emerge. Recent studies have highlighted multiple shared characteristics between NK cells the adaptive immune lymphocytes. NK cells utilize unique signaling pathways that offer exclusive ways to genetically manipulate to improve their effector functions. Here, we summarize the recent advances made in the understanding of how NK cells develop, mature, and their potential translational use in the clinic.
登录
查看更多内容
影响因子:
3.7
作者:
Abdul-Careem MF;Lee AJ;Pek EA;Gill N;Gillgrass AE;Chew MV;Reid S;Ashkar AA
通讯作者:
Ashkar AA
DOI:
10.1016/j.bbmt.2009.01.018
发表时间:
2009-05
期刊:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
影响因子:
--
作者:
Baron F;Petersdorf EW;Gooley T;Sandmaier BM;Malkki M;Chauncey TR;Maloney DG;Storb R
通讯作者:
Storb R
DOI:
10.1073/pnas.91.11.4940
发表时间:
1994-05-24
影响因子:
11.1
作者:
BAMFORD, RN;GRANT, AJ;WALDMANN, TA
通讯作者:
WALDMANN, TA
影响因子:
56.9
作者:
Bauer, S;Groh, V;Spies, T
通讯作者:
Spies, T
影响因子:
5.8
作者:
Ash, Shifra;Gigi, Vered;Yaniv, Isaac
通讯作者:
Yaniv, Isaac